PMCB
Pharmacyte Biotech
$0.59
−$0.02 (−2.5%)Jul 27, 2026
Key metrics
The numbers that frame PMCB today
- Market cap
- $6.28M
- P/E (TTM)
- -1.9
- EV / FCF
- 2.9
- ROIC
- -9.7%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.57
- 52wk High
- $1.51
Growth
Revenue and earnings trend for PMCB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PMCB
Is Pharmacyte Biotech a good buy?
No. Pharmacyte Biotech has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of PMCB?
Pharmacyte Biotech's market capitalization is $6.28M.
What is the P/E ratio for PMCB stock?
Pharmacyte Biotech's current P/E ratio is -1.9.
What is the 52-week high for PMCB stock?
The 52-week high for Pharmacyte Biotech is $1.51. The current close of $0.59 is 61.3% below that high.
What is the 52-week low for PMCB stock?
The 52-week low for Pharmacyte Biotech is $0.57. The current close of $0.59 is 2.5% above that low.
Does PMCB stock pay dividends?
Pharmacyte Biotech does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PMCB?
Pharmacyte Biotech's Debt / Equity ratio is 0.